| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |